接种COVID-19疫苗将COVID阳性髋部骨折患者的死亡风险降至基线水平:全国性数据链接IMPACT Protect研究
该全国性队列研究利用数据链接记录评估COVID-19疫苗接种对苏格兰50岁以上髋部骨折患者的影响。接种疫苗与较低的COVID-19感染风险相关(OR 0.41,95%CI 0.34-0.48,p<0.001);在COVID阳性患者中,接种疫苗者的死亡风险与COVID阴性患者相似(OR 0.93,95%CI 0.53-1.60,p=0.783)。
要点
- 接种疫苗的髋部骨折患者感染COVID-19的几率较低(OR 0.41,95%CI 0.34-0.48,p<0.001)。
- 未接种疫苗的COVID阳性患者死亡风险高于COVID阴性患者(OR 2.77,95%CI 2.12-3.62,p<0.001)。
- 接种疫苗的COVID阳性患者死亡风险与COVID阴性患者无显著差异(OR 0.93,95%CI 0.53-1.60,p=0.783)。
核心结论
- 接种疫苗与较低的COVID-19感染风险相关;接种疫苗的COVID阳性患者死亡风险与COVID阴性患者相似,提示感染严重程度降低。
主要发现
- 3022/13345(22.6%)患者诊断为COVID-19,其中606/13345(4.5%)在骨折后30天内COVID阳性。
- 接种疫苗患者COVID阳性的比值比(OR)为0.41(95%CI 0.34-0.48,p<0.001),低于未接种疫苗患者。
- COVID阳性患者30天死亡率高于COVID阴性患者(15.8% vs 7.9%,p<0.001)。
- 控制混杂因素后,未接种疫苗的COVID阳性患者死亡风险高于COVID阴性患者(OR 2.77,95%CI 2.12-3.62,p<0.001);接种疫苗的COVID阳性患者死亡风险未显著增加(OR 0.93,95%CI 0.53-1.60,p=0.783)。
关键数值与推荐
- 接种疫苗患者COVID阳性的OR 0.41(95%CI 0.34-0.48,p<0.001)。
- 未接种疫苗COVID阳性患者死亡OR 2.77(95%CI 2.12-3.62,p<0.001)。
- 接种疫苗COVID阳性患者死亡OR 0.93(95%CI 0.53-1.60,p=0.783)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
UNLABELLED: This nationwide study used data-linked records to assess the effect of COVID-19 vaccination among hip fracture patients. Vaccination was associated with a lower risk of contracting COVID-19 and, among COVID-positive patients, it reduced the mortality risk to that of COVID-negative patients. This provides essential data for future communicable disease outbreaks. PURPOSE: COVID-19 confers a three-fold increased mortality risk among hip fracture patients. The aims were to investigate whether vaccination was associated with: i) lower mortality risk, and ii) lower likelihood of contracting COVID-19 within 30 days of fracture. METHODS: This nationwide cohort study included all patients aged > 50 years that sustained a hip fracture in Scotland between 01/03/20-31/12/21. Data from the Scottish Hip Fracture Audit were collected and included: demographics, injury and management variables, discharge destination, and 30-day mortality status. These variables were linked to government-managed population level records of COVID-19 vaccination and laboratory testing. RESULTS: There were 13,345 patients with a median age of 82.0 years (IQR 74.0-88.0), and 9329/13345 (69.9%) were female. Of 3022/13345 (22.6%) patients diagnosed with COVID-19, 606/13345 (4.5%) were COVID-positive within 30 days of fracture. Multivariable logistic regression demonstrated that vaccinated patients were less likely to be COVID-positive (odds ratio (OR) 0.41, 95% confidence interval (CI) 0.34-0.48, p < 0.001) than unvaccinated patients. 30-day mortality rate was higher for COVID-positive than COVID-negative patients (15.8% vs 7.9%, p < 0.001). Controlling for confounders (age, sex, comorbidity, deprivation, pre-fracture residence), unvaccinated patients with COVID-19 had a greater mortality risk than COVID-negative patients (OR 2.77, CI 2.12-3.62, p < 0.001), but vaccinated COVID19-positive patients were not at increased risk of death (OR 0.93, CI 0.53-1.60, p = 0.783). CONCLUSION: Vaccination was associated with lower COVID-19 infection risk. Vaccinated COVID-positive patients had a similar mortality risk to COVID-negative patients, suggesting a reduced severity of infection. This study demonstrates the efficacy of vaccination in this vulnerable patient group, and presents data that will be valid in the management of future outbreaks.
引用
- Hall AJ, Clement ND, MacLullich AMJ, et al. Vaccination against COVID-19 reduced the mortality risk of COVID-positive hip fracture patients to baseline levels: the nationwide data-linked IMPACT Protect study. Osteoporos Int. 2023. PMID: 37897507. doi:10.1007/s00198-023-06954-w
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。